A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: Implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neurovirology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/13550280152537157PMID 11517408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• JC Virus Enters Human Glial Cells by Clathrin-Dependent Receptor-Mediated Endocytosis

  2000cited by this paper
• Examination of Potential Inhibitors of Hepatitis A Virus Uncoating

  1999cited by this paper
• Infection of Glial Cells by the Human Polyomavirus JC Is Mediated by an N-Linked Glycoprotein Containing Terminal α(2-6)-Linked Sialic Acids

  1998cited by this paper
• Inhibition of HIV infection of H9 cells by chlorpromazine derivatives.

  1997cited by this paper
• Inhibition of arenavirus multiplication in vitro by phenotiazines.

  1996cited by this paper
• Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells.

  1995influential reference
• Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation

  1993cited by this paper
• Inhibition of SV40 DNA replication in vitro by chlorpromazine.

  1993cited by this paper
• Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region.

  1989influential reference
• Internalization and recycling of transferrin and its receptor. Effect of trifluoperazine on recycling in human erythroleukemic cells.

  1986cited by this paper
• Establishment of a line of human fetal glial cells that supports JC virus multiplication.

  1985cited by this paper
• Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

  1970cited by this paper

• Sintilimab for treating progressive multifocal leukoencephalopathy caused by human polyomavirus 2 virus infection following allogeneic hematopoietic cell transplantation: a case report

  2025cites this paper
• Highly restrictive and directional penetration of the blood cerebral spinal fluid barrier by JCPyV

  2024cites this paper
• Onaylanmış Merkezi Etkili İlaçların Antiviral Aktivitesi: Bir Anlatı İncelemesi

  2022cites this paper
• Capturing and Quantifying Particle Transcytosis with Microphysiological Intestine‐on‐Chip Models

  2022cites this paper
• Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?

  2020cites this paper
• Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation: Case report and review of the literature

  2018cites this paper
• Investigating the Mechanism of JC Polyomavirus Endocytosis

  2017cites this paper
• Rhodiolae Kirliowii Radix et Rhizoma and Crataegus pinnatifida Fructus Extracts Effectively Inhibit BK Virus and JC Virus Infection of Host Cells

  2017cites this paper
• Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies

  2017cites this paper
• Possible Biological and Clinical Applications of Phenothiazines.

  2017cites this paper
• Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?

  2017cites this paper
• Antimicrobial Activity of Phenothiazines and Evolution of Anti-Tubercular agents from Non-Antibiotics : Hope against Multi Drug Resistant Tuberculosis

  2017cites this paper
• Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions

  2016cites this paper
• Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

  2015cites this paper
• Phenothiazine‐Derived Antipsychotic Drugs Inhibit Dynamin and Clathrin‐Mediated Endocytosis

  2015cites this paper
• Therapeutic Advances in Neurological Disorders

  2015influential citation
• Antiviral Therapy for Progressive Multifocal Leukoencephalopathy

  2014cites this paper
• Anticorps humains recombinants destinés à la thérapie et à la prévention de maladies associées aux polyomavirus

  2014cites this paper
• Scavenger receptor-recognized and enzyme-responsive nanoprobe for fluorescent labeling of lysosomes in live cells.

  2014cites this paper
• Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy.

  2014cites this paper
• JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?

  2013cites this paper
• Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres

  2013cites this paper
• Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors.

  2013cites this paper
• Human Brain theVirus-Induced Demyelinating Disease of Leukoencephalopathy , the JC Pathogenesis of Progressive Multifocal

  2012cites this paper
• Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain

  2012cites this paper
• Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous.

  2012cites this paper
• Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy

  2011cites this paper
• Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy

  2010cites this paper
• Hematopoietic cell transplantation and emerging viral infections

  2010cites this paper
• An unusual complication of immunosuppression in myasthenia gravis: progressive multifocal leukoencephalopathy.

  2009cites this paper
• Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.

  2009cites this paper
• Compositions et procédés de traitement de la leucoencéphalopathie multifocale progressive (lemp)

  2008cites this paper
• Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature

  2007cites this paper
• Myristyl Trimethyl Ammonium Bromide and Octadecyl Trimethyl Ammonium Bromide Are Surface-Active Small Molecule Dynamin Inhibitors that Block Endocytosis Mediated by Dynamin I or Dynamin II

  2007cites this paper
• Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry

  2007cites this paper
• The pathobiology of polyomavirus infection in man.

  2006cites this paper
• Pharmacotherapeutic options for the management of human polyomaviruses.

  2006cites this paper
• Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins.

  2005cites this paper
• Management of infections by the human polyomavirus JC: past, present and future

  2005cites this paper
• Polyomavirus Nephropathy in Kidney Transplantation

  2004cites this paper
• Antimicrobial activity of phenothiazines.

  2004cites this paper
• Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy

  2003cites this paper